ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SEP Standard Life European Private Equity Trust

298.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Standard Life European Private Equity Trust LSE:SEP London Ordinary Share GB0030474687 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 298.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Standard Life Euro Pri Eqty Tst PLC Estimated Net Asset Value at 30 November 2016 (7115R)

14/12/2016 7:00am

UK Regulatory


Standard Life European Private E (LSE:SEP)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Standard Life European Private E Charts.

TIDMSEP

RNS Number : 7115R

Standard Life Euro Pri Eqty Tst PLC

14 December 2016

14 December 2016

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 30 NOVEMBER 2016

-- ESTIMATED NAV AT 30 NOVEMBER 2016 WAS 342.3 PENCE PER SHARE (ESTIMATED NAV AT 31 OCTOBER 2016 WAS 358.9 PENCE PER SHARE)

-- SLEPET PAID GBP5.9 MILLION OF DRAW DOWNS AND RECEIVED GBP5.0 MILLION OF DISTRIBUTIONS DURING THE MONTH OF NOVEMBER

   --      OUTSTANDING COMMITMENTS OF GBP325.2 MILLION AT 30 NOVEMBER 2016 

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which the Company has interests. In the case of SLEPET's valuation at 30 November 2016, 98.7% by value of the portfolio valuations were dated 30 September 2016.

Estimated NAV

At 30 November 2016, SLEPET's estimated NAV was 342.3 pence per share (estimated net assets GBP526.3 million), representing a 4.6% per share decrease from the estimated NAV at 31 October 2016 of 358.9 pence per share (estimated net assets GBP551.8 million). The 16.6 pence decrease in NAV primarily reflected unrealised foreign exchange losses arising from a 5.7% depreciation in the euro versus sterling during November.

Draw downs and distributions

SLEPET paid GBP5.9 million of draw downs and received GBP5.0 million of distributions during the month. The distributions received generated net realised gains and income of GBP2.0 million.

Commitments

The Company had GBP325.2 million of outstanding commitments at 30 November 2016. After undertaking a detailed review, the Manager continues to believe that around GBP55 million of the Company's existing outstanding commitments are unlikely to be drawn.

Balance sheet and credit facility

The Company had liquid resources of GBP110.6 million at 30 November 2016. In addition, the Company has an undrawn GBP80 million syndicated revolving credit facility, provided by Citibank and Societe Generale that expires in December 2020.

Future announcements

The Company is expecting to announce its estimated NAV at 31 December 2016 on 16 January 2017.

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact Roger Pim or Peter McKellar at SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the latest monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVFFISUDFMSEIE

(END) Dow Jones Newswires

December 14, 2016 02:00 ET (07:00 GMT)

1 Year Standard Life European Private E Chart

1 Year Standard Life European Private E Chart

1 Month Standard Life European Private E Chart

1 Month Standard Life European Private E Chart

Your Recent History

Delayed Upgrade Clock